IRD Opus Genetics, Inc.
Price Chart
Executive Summary
Opus Genetics issued $35 million in senior secured notes as the first tranche of a $155 million financing facility. The notes mature in 2033, bear a floating interest rate based on Term SOFR, and are secured by substantially all company assets.
Actionable Insight
Monitor future tranches of this facility for additional funding draws, which could signal advancement of development milestones. The secured nature of the debt increases risk to existing equity holders if the company encounters financial difficulty.
Key Facts
- Opus Genetics issued $35 million in senior secured notes on April 21, 2026
- The notes are part of a larger $155 million facility, with $105 million committed and $50 million uncommitted
- Notes mature on April 21, 2033, and bear interest at a floating rate based on Term SOFR plus a margin
- Obligations are secured by substantially all assets of the company and its subsidiaries
- Funding is subject to customary conditions and milestone achievements for future tranches
Financial Impact
$35 million in new debt issued, increasing leverage; total facility potential of $155 million
Risk Factors
- Increased leverage with secured debt could limit future financing options
- Floating interest rate exposes the company to rate hike risk
- Future draws on the facility may lead to additional dilution or restrictive covenants
Market Snapshot
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001140361-26-016764 |
| Document: 0001140361-26-016764-index-headers.html | 0001140361-26-016764 |
| Document: 0001140361-26-016764-index.html | 0001140361-26-016764 |
| Document: 0001140361-26-016764.txt | 0001140361-26-016764 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 5, 2026
7d ago
|
S-3
| $4.61 awaiting T+5 | awaiting T+5 | — | $4.04 (+12.36%) |
|
May 12, 2026
4w ago
|
8-K
| $5.18 $4.44 | ▼ −14.29% | ▼ −14.36% | $4.04 (−22.01%) |
|
May 12, 2026
4w ago
|
Press Release
| $5.18 $4.44 | ▲ +14.29% | ▲ +14.36% | $4.04 (+22.01%) |
|
May 7, 2026
5w ago
|
Press Release
| $4.99 $4.97 | ▼ −0.40% | ▼ −1.86% | $4.04 (−19.04%) |
|
Apr 24, 2026
7w ago
|
8-K
| $5.12 $5.22 | ▲ +1.95% | ▲ +1.55% | $4.04 (−21.09%) |
|
Apr 23, 2026
7w ago
|
EFFECT
| $5.21 $4.67 | ▼ −10.36% | ▼ −11.84% | $4.04 (−22.46%) |
|
Apr 23, 2026
7w ago
|
Insider Cluster
| $5.21 $4.67 | ▼ −10.36% | ▼ −11.84% | $4.04 (−22.46%) |
|
Apr 10, 2026
9w ago
|
Press Release
| $5.36 $5.75 | ▲ +7.28% | ▲ +2.77% | $4.04 (−24.63%) |
|
Apr 7, 2026
9w ago
|
8-K
| $4.92 $5.55 | ▲ +12.80% | ▲ +7.48% | $4.04 (−17.89%) |
|
Mar 16, 2026
12w ago
|
Insider Cluster
| $5.19 $4.59 | ▼ −11.56% | ▼ −9.52% | $4.04 (−22.16%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access